However, these data must be treated with caution, as no clear cut evidence for a beneficial role of anti-IL-17 treatment (other than that related to skin lesions and arthritis) in managing anxiety, depression is currently provided, and data by no means are conclusive. The gene discussed is IL17A; the disease is arthritic joint disease.